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A B S T R A C T
Protein kinases constitute one of the largest protein families in nature. Current methods to assay their activity
involve the use of radioactive ATP or very expensive reagents. In this work, we developed a highly sensitive,
cost-eﬀective and straightforward protocol to measure protein kinase activity using a microplate layout.
Released ADP is converted into NAD+, which is quantiﬁed by its ﬂuorescent properties after alkaline treatment
(linear range 0–10 nmol ADP). To validate our protocol, we characterized a recombinant calcium-dependent
protein kinase from potato. Overall, this tool represents a critical step forward in the functional characterization
of protein kinases.
Protein phosphorylation is one of the most studied post-transla-
tional modiﬁcations because it regulates almost every aspect of cellular
function [1,2]. Eukaryotic protein kinases (PKs, EC 2.7.11.-) transfer a
single phosphoryl group from the γ position of ATP to the hydroxyl
groups of serine, threonine and tyrosine residues in protein substrates
(Supplemental Fig. S1) [3]. Abnormal protein phosphorylation has been
linked to several diseases; thus, PKs are intensively studied in drug-
discovery experiments [4]. The main diﬃculty to assay PKs is their
intrinsic, low turnover rates (10−2-10−5 s−1) [5]. Several methods
have been developed to measure PK activity (Supplemental Fig. S1), but
only those based on ADP quantiﬁcation can be applied to all PK/sub-
strate combinations [6].
The radioactive assay (Supplemental Fig. S1) was the ﬁrst method
used to measure PK activity and is considered the gold standard due to
its high sensitivity and robustness [7–10]. As drawbacks, it is time-
consuming and generates a large amount of radioactive waste. Non-
radioactive methods to assay PK activity are based on peptide or ADP
detection (Supplemental Fig. S1). In general, peptide-dependent
methods have low sensitivity and can neither be adapted to PKs with
unknown motif preference nor used with native proteins as substrates.
Among methods to detect ADP, Transcreener ADP2 Kinase Assay
(BellBrook Labs) is the only one that allows direct detection of ADP; it is
highly sensitive but very expensive. Coupled methods are based on the
use of enzymes to detect the products of the phosphorylation reaction,
being ADP-Glo (Promega) the main assay currently available on the
market. It measures released ADP using an enzymatic tandem to gen-
erate a luminescent signal. This is a highly sensitive method but it is
quite expensive and sensitive to compounds that inhibit luciferase
[11,12].
In this work, we adapted the enzymatic tandem pyruvate kinase/
lactate dehydrogenase to assay PK activity [9]. Released ADP is con-
verted into NAD+, which can be quantiﬁed using a ﬂuorescence de-
tector after the alkaline treatment initially described by Kaplan et al.
[13] and further adapted by other authors [14,15] (Supplemental Fig.
S2). We characterized a plant PK in parallel with the radioactive
method, the ADP-Glo reagent and the ﬂuorometric method. We show
this is a cost-eﬀective method, suitable to assay PK activity without
radioactive ATP and with any type of substrate.
Solanum tuberosum Calcium Dependent Protein Kinase 1 (StCDPK1)
was expressed as described by Santin et al. [16], with minor mod-
iﬁcations. Transformed cells were grown in LB medium supplemented
with 100 μgml−1 ampicillin and induced with 0.5mM isopropyl-β-D-1-
thiogalactopyranoside for 16 h at 30 °C and 180 rpm. Cells were col-
lected by centrifugation, resuspended in lysis buﬀer [25mM Tris-HCl
pH 8.0, 300mM NaCl, 5% (v/v) glycerol and 10mM imidazole], dis-
rupted by sonication and centrifuged twice at 16000× g for 20min at
4 °C. The crude extract was loaded onto a 1-ml HisTrap HP column (GE
Healthcare) previously equilibrated with lysis buﬀer. The enzyme was
eluted with a linear imidazole gradient (10–300mM) in lysis buﬀer.
Fractions containing PK activity were pooled, concentrated and stored
at −80 °C until use.
StCDPK1 activity was assayed as described by Raíces et al. [17].
Brieﬂy, the enzyme was incubated for 5min in 20mM Tris-HCl pH 7.5,
10mMMgCl2, 1 mM DTT, 1mM CaCl2, 50 μM ATP and 100 μM Syntide-
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2 peptide at 30 °C (a detailed list of all reagents used as well as pre-
paration and storage considerations are available in Supplemental
Table S1). Activity measurements with the radioactive method were
done in a ﬁnal volume of 20 μl, following a previously described pro-
tocol [10]. Activity measurements with the ADP-Glo reagent (Promega)
were done in a ﬁnal volume of 5 μl, according to the manufacturer's
instructions.
Reactions with the ﬂuorometric assay were performed in a ﬁnal
volume of 20 μl in black 96-well microplates (Thermo Scientiﬁc) as
described above, with the addition of the system necessary to convert
released ADP into NAD+ (2mM phosphoenolpyruvate, 2 mM NADH, 1
U lactate dehydrogenase and 1 U pyruvate kinase) to the PK reaction.
Reactions were stopped with 20 μl 0.3 M HCl and incubated for
20min at room temperature to remove excess NADH (Supplemental
Fig. S3). Then, 170 μl 9 M NaOH were added and samples were in-
cubated at room temperature in the dark for 60min to develop the
NAD+ alkaline derivates. Fluorescence was quantiﬁed in a ﬂuorometer
(Fluoroskan Ascent FL, Thermo Scientiﬁc) using excitation and emis-
sion ﬁlters of 355 and 460 nm, respectively, with an integration time of
20ms. The amount of generated ADP was calculated using an ADP
standard curve constructed using the same conditions. A detailed step
by step procedure with key experimental details is presented in
Supplemental Fig. S2. Data were analyzed with OriginPro 8 (OriginLab
Corporation). Kinetic parameters were obtained by ﬁtting data of en-
zyme activity versus substrate concentration using a modiﬁed Hill
equation: v= Vmax*SnH/(S0.5nH + SnH); where v is the initial velocity,
S0.5 is the concentration of substrate (S) that produces 50% of the
maximal velocity (Vmax), and nH is the Hill coeﬃcient. One unit (U) is
deﬁned as the amount of enzyme that catalyzes the formation of 1 μmol
of ADP per minute under the speciﬁed assay conditions.
The radioactive assay detects phosphopeptide formation in the na-
nomolar range; thus, we optimized conditions to measure ADP in such a
range. Standard curves were made in a ﬁnal volume of 20 μl with in-
creasing amounts of ADP (0–0.5mM; 0–10 nmol). Curves were linear
with a slope of 420 ± 7 RFU mM−1 (Adjusted R2=1.00, P < 0.001;
Supplemental Figs. S4A–B). We obtained identical results when cali-
bration curves were performed with NAD+ (Supplemental Fig. S4 A-B),
indicating complete conversion of ADP into NAD+ with the pyruvate
kinase/lactate dehydrogenase system. Under our assay conditions,
limits of detection and quantiﬁcation for ADP were 0.05 and 0.15 nmol,
respectively (Supplemental Fig. S4C). The ﬂuorometric method showed
adequate reproducibility, according to the coeﬃcient of variation (CV)
obtained for calibration curves (average < 5%) and StCDPK1 activity
assays (average < 15%). We also obtained a good signal to back-
ground ratio (S:B) and a Z factor > 0.5 above 15 μM ADP
(Supplemental Fig. S4D), suggesting potential application in high-
throughput screenings. Equations used for calculating LOD, LOQ, S:B
and Z factor are presented in Supplemental Information S1.
To validate our method, we performed StCDPK1 activity assays with
our ﬂuorometric method in parallel with the radioactive and ADP-Glo
methods. We observed a linear correlation (in the analyzed range of
product formation, 0–1 nmol) between the ﬂuorometric and radioactive
methods (Slope= 1.04 ± 0.03, R2= 0.99, P < 0.001; Fig. 1A). Si-
milar results were obtained between the ﬂuorometric method and the
ADP-Glo reagent (Slope=0.98 ± 0.07, R2= 0.95, P < 0.001;
Fig. 1B).
Kinetic parameters for StCDPK1 using Syntide-2 as substrate de-
termined with the ﬂuorometric method were similar to those obtained
in parallel with the radioactive method and the ADP-Glo reagent
(Table 1 and Supplemental Fig. S4), although slightly diﬀerent to the
ones reported by Grandellis et al. [18]. We also obtained identical re-
sults with the ﬂuorometric and radioactive methods when StCDPK1
activity was assayed with myelin basic protein as substrate (1.5 ± 0.3
and 1.6 ± 0.3 mU mg−1, respectively).
The ﬂuorometric method described in this work is intended for the
functional characterization of PKs. Our method is highly sensitive,
which makes it suitable for activity assays in small reaction volumes,
either with peptides or proteins as substrates. This is of great interest
because PKs phosphorylate proteins more eﬃciently than artiﬁcial
peptides [3]. Another advantage of using pyruvate kinase in the PK
reaction is that released ADP is recycled back to ATP, thus maintaining
a constant substrate concentration [19] (Supplemental Fig. S2). This
ensures initial velocity conditions over the course of the enzymatic
reaction and avoids PK inhibition by ADP [19,20].
The main drawback of our method is that it cannot be used to
Fig. 1. Validation of the ﬂuorometric method for PK activity assays. Data of released ADP (ﬂuorometric method, y-axis in A and B) were plotted against incorporated
[32P]phosphate (radioactive method, x-axis in A) or released ADP (ADP-Glo method, x-axis in B). Data are the mean of two independent experiments ± standard
error.
Table 1
Characterization of StCDPK1 with three diﬀerent methods. Kinetic parameters
were calculated by ﬁtting activity data to a modiﬁed Hill equation, as described
in the main text.
Parameter Radioactive ADP-Glo Fluorometric
Vmax (U mg−1) 1.21 ± 0.04 1.2 ± 0.1 1.23 ± 0.06
ATP S0.5 (μM) 63 ± 6 54 ± 17 78 ± 11
nH 1.5 ± 0.2 0.8 ± 0.1 1.3 ± 0.2
Adjusted R2 0.99 0.98 0.99
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reliably assay PK activity in crude extracts. This is mainly due to the
presence of ATPases and non-speciﬁc phosphatases, which release ADP
and thus increase reaction blanks [12]. Also, the ﬂourometric method
could not be employed to assay PKs with ATP S0.5 values close to or
lower than its detection limit [21]. Besides that, we envisage that our
assay will be of great help for the biochemical characterization of PKs.
It is worth mentioning that the cost per reaction of the ﬂuorometric
method is signiﬁcantly lower than the radioactive method (5-fold) and
the ADP-Glo reagent (19-fold). Kinetic parameters obtained for
StCDPK1 with all methods used herein (ﬂuorometric, radioactive and
ADP-Glo) are in good agreement with those previously reported for
other CDPKs (Table 1 and Supplemental Table S2). Therefore, we
conclude that the ﬂuorometric method developed in this work re-
presents an important tool better understand the function of PKs.
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